NCT02892006 is a NA clinical trial of Improvisational Comedy in Distress, sponsored by Cedars-Sinai Medical Center.

Who is sponsoring NCT02892006?

NCT02892006 is sponsored by Cedars-Sinai Medical Center.

What drugs are being tested in NCT02892006?

Interventions in NCT02892006: Improvisational Comedy.

What condition does NCT02892006 study?

NCT02892006 studies Distress, Breast Neoplasms, Quality of Life.

Is NCT02892006 still recruiting?

NCT02892006 is currently completed. Last updated 7 September 2018.

Last reviewed 2018-09-07 · How we verify

NCT02892006

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LOL: It's All Improv After Cancer! The Impact of Improvisational Comedy on Well-Being Among Patients With Cancer

Completed NA Last updated 7 September 2018

What this trial tests

NA trial testing Improvisational Comedy in Distress in 20 participants. Completed in 20 December 2017.

Timeline

30 November 2016

Primary endpoint
20 December 2017

20 December 2017

Quick facts

Lead sponsor	Cedars-Sinai Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	30 November 2016
Primary completion	20 December 2017
Estimated completion	20 December 2017
Sites	1 location across United States

Drugs / interventions tested

Improvisational Comedy

Conditions studied

Distress — all drugs for Distress →
Breast Neoplasms — all drugs for Breast Neoplasms →
Quality of Life — all drugs for Quality of Life →

Sponsor

Cedars-Sinai Medical Center

Who can join

18 and older, female only, with Distress or Breast Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Managing distress and improving well-being is critically important for optimal survivorship care. Treatment of distress leads to better adherence to treatment, better communication, fewer calls and visits to the oncologist's office, and avoidance of development of severe anxiety or depression. Based on national guidelines, distress is typically managed with pharmacologic options (i.e. benzodiazepines), support groups, individual counseling, or chaplaincy services. To our knowledge, the role of a structured improvisational comedy (improv) program in reducing distress and improving well-being has never been evaluated in the oncology setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cedars-Sinai Medical Center trials

Trials by the same sponsor.

NCT06012487 — Correlates and Control of Blood Pressure Variability · Phase 1 · not yet recruiting
NCT07495995 — SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis · Phase 2 · not yet recruiting
NCT07413965 — TAVR vs SAVR in Severe Bicuspid Aortic Stenosis · NA · not yet recruiting
NCT06521021 — CHOICE to AVOID or RESIST · NA · not yet recruiting
NCT07499089 — Together-Breast Cancer Support Platform · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02892006 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cedars-Sinai Medical Center
Last refreshed: 7 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02892006.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing